Octapharma’s core business is the development, production and sale of safe and effective medicines derived from human proteins in the following areas:
- Haematology (coagulation disorders)
- Immunotherapy (immune disorders)
- Intensive Care and Emergency Medicine
Octapharma is an independent, Swiss-based company founded in 1983.
